Skip to main navigation

Investors

News Archive
Past Events and Presentations
Stock History

News Archive

News Archive

Items Per Page

Year

Jul 02, 2007

Mylan Announces Final FDA Approval for Terbinafine Hydrochloride Tablets

Jun 25, 2007

Mylan Announces Final FDA Approval for Ondansetron Hydrochloride Tablets and Ondansetron Orally Disintegrating Tablets, USP

Jun 18, 2007

Mylan Declares Quarterly Cash Dividend of $0.06 Per Share

Jun 08, 2007

Mylan Announces Final FDA Approval for Doxycycline Tablets, 150mg

Jun 05, 2007

Mylan Wins Its Amlodipine Case With Pfizer

May 31, 2007

Mylan Announces Final FDA Approval for Azithromycin Tablets

May 31, 2007

Mylan Announces Tentative FDA Approval for Paroxetine Hydrochloride Extended-Release Tablets

May 31, 2007

Mylan Wins Omeprazole Patent Litigation

May 30, 2007

Mylan Announces Final FDA Approval for Fluoxetine Capsules USP, 40 mg

May 24, 2007

Mylan Reports Fourth Quarter & Fiscal 2007 Adjusted Diluted EPS of $0.47 & $1.65 Excluding any Contribution from Amlodipine

Pagination

First page
Previous page
…
Page 97
Page 98
Page 99
Page 100
Current page 101
Page 102
Page 103
Page 104
Page 105
…
Next page
Last page

Share

Utility Nav

Privacy Statement
Terms and Conditions

©2025 Mylan N.V. All rights reserved. The Mylan logo is a registered trademark of Mylan Inc.